Filters: author is Langemeijer [Clear All Filters]
- 1999
Pilot study in humans on the pharmacokinetics and safety of propofol 6% SAZN,
Pharm World Sci, vol. 21, no. 5, pp. 239-40.
Pharmacokinetics, induction of anaesthesia and safety characteristics of propofol 6% SAZN vs propofol 1% SAZN and Diprivan-10 after bolus injection,
Br J Clin Pharmacol, vol. 47, no. 6, pp. 653-60.
The comparative pharmacodynamics of remifentanil and its metabolite, GR90291, in a rat electroencephalographic model,
Anesthesiology, vol. 90, no. 2, pp. 535-44.
- 1998
Metabolic and cardiovascular effects of the adenosine A1 receptor agonist N6-(p-sulfophenyl)adenosine in diabetic Zucker rats: influence of the disease on the selectivity of action,
J Pharmacol Exp Ther, vol. 287, no. 1, pp. 21-30.
Influence of different fat emulsion-based intravenous formulations on the pharmacokinetics and pharmacodynamics of propofol,
Pharm Res, vol. 15, no. 3, pp. 442-8.
Pharmacokinetic-pharmacodynamic modelling of the analgesic effect of alfentanil in the rat using tooth pulp evoked potentials,
J Pharmacol Toxicol Methods, vol. 39, no. 1, pp. 19-27.
- 1997
Pharmacokinetic-pharmacodynamic modelling of the anti-lipolytic and anti-ketotic effects of the adenosine A1-receptor agonist N6-(p-sulphophenyl)adenosine in rats,
Br J Pharmacol, vol. 122, no. 3, pp. 525-33.
8-Alkylamino-substituted analogs of N6-cyclopentyladenosine are partial agonists for the cardiovascular adenosine A1 receptors in vivo,
J Pharmacol Exp Ther, vol. 283, no. 2, pp. 800-8.
- 1995
Modelling of the pharmacodynamic interaction of an A1 adenosine receptor agonist and antagonist in vivo: N6-cyclopentyladenosine and 8-cyclopentyltheophylline,
Br J Pharmacol, vol. 115, no. 7, pp. 1253-9.
- 1994
Pharmacokinetic-pharmacodynamic relationship of the cardiovascular effects of adenosine A1 receptor agonist N6-cyclopentyladenosine in the rat,
J Pharmacol Exp Ther, vol. 268, no. 2, pp. 616-24.
- 1993
Increased sensitivity to the anticonvulsant effect of valproate in aging BN/BiRij rats,
Pharm Res, vol. 10, no. 7, pp. 1046-51.
- 1992
Pharmacokinetic-EEG effect relationship of midazolam in aging BN/BiRij rats,
Br J Pharmacol, vol. 107, no. 1, pp. 171-7.
Pharmacodynamics of the anticonvulsant effect of oxazepam in aging BN/BiRij rats,
Br J Pharmacol, vol. 107, no. 1, pp. 165-70.
- 1990
Pharmacokinetic-pharmacodynamic modelling of the anticonvulsant effect of oxazepam in individual rats,
Br J Pharmacol, vol. 99, no. 1, pp. 53-8.
- 1989
Relationship between receptor occupancy at 37 degrees C and the anticonvulsant effect of flunitrazepam in rats,
Pharm Res, vol. 6, no. 7, pp. 585-91.
- 1988



